Abingworth as of June 30, 2022
Portfolio Holdings for Abingworth
Abingworth holds 21 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 29.0 | $91M | 4.2M | 21.76 | |
| Sierra Oncology Common | 23.1 | $72M | 1.3M | 55.00 | |
| Vera Common (VERA) | 12.9 | $40M | 3.0M | 13.61 | |
| Adicet Common (ACET) | 9.9 | $31M | 2.1M | 14.60 | |
| Hillevax Common (HLVX) | 6.4 | $20M | 1.8M | 10.84 | |
| Phathom Common (PHAT) | 3.9 | $12M | 1.4M | 8.44 | |
| Jasper Common | 3.4 | $11M | 5.6M | 1.89 | |
| Verona Sponds Adr (VRNA) | 3.3 | $10M | 2.5M | 4.14 | |
| eFFECTOR Common | 2.1 | $6.5M | 4.8M | 1.34 | |
| Reneo Common (RPHM) | 1.7 | $5.4M | 2.1M | 2.61 | |
| Soleno Common | 1.0 | $3.2M | 18M | 0.18 | |
| Spruce Bio Common | 1.0 | $3.1M | 1.8M | 1.73 | |
| Nucana Adr | 0.8 | $2.4M | 3.3M | 0.73 | |
| Paratek Common | 0.6 | $2.0M | 1.0M | 1.92 | |
| Sientra Common | 0.4 | $1.4M | 1.7M | 0.83 | |
| Exicure Common | 0.2 | $594k | 282k | 2.11 | |
| Cymabay Common | 0.1 | $385k | 131k | 2.94 | |
| Molecular Templates Common | 0.1 | $182k | 200k | 0.91 | |
| Obseva Common | 0.0 | $141k | 88k | 1.60 | |
| Aeglea Common | 0.0 | $121k | 241k | 0.50 | |
| Ocugen Common | 0.0 | $16k | 7.1k | 2.25 |
